Abstract
Abstract
Objectives
The development and strengthening of health technology assessment (HTA) capacity on the individual and organizational level and the wider environment is relevant for cooperation on HTAs. Based on the Maltese case, we provide a blueprint for building HTA capacity.
Methods
A set of activities were developed based on Pichler et al.’s framework and the starting HTA capacity in Malta. Individual level activities focused on strengthening epidemiological and health economic skills through online and in-person training. On the organizational level, a new HTA framework was developed which was subsequently utilized in a shadow assessment. Awareness campaign activities raised awareness and support in the wider environment where HTAs are conducted and utilized.
Results
The time needed to build HTA capacity exceeded the planned two years accommodating the learning progress of the assessors. In addition to the planned trainings, webinars supplemented the online courses, allowing for more knowledge exchange. The advanced online course was extended over time to facilitate learning next to the assessors’ daily tasks. Training sessions were added to implement the new economic evaluation framework, which was utilized in a second shadow assessment. Awareness by decision-makers was achieved with reports, posters, and an article on the current and developing HTA capacity.
Conclusions
It takes time and much (hands-on) training to build skills for conducting complex assessment such as HTAs. Facilitating exchange with knowledgeable parties is crucial for succeeding as well as the buy-in of local managers motivating staff. Decision-makers need to be on-boarded for the continued success of HTA capacity building.
Publisher
Cambridge University Press (CUP)
Reference12 articles.
1. Health Technology Assessment in Thailand: Institutionalization and Contribution to Healthcare Decision Making: Review of Literature
2. 1. European Commission EUR-Lex [Internet]. Regulation (EU) 2021/2282 of the European Parliament and of the Council of 15 December 2021 on health technology assessment and amending Directive 2011/24/EU (Text with EEA relevance) [cited 2022 Dec 12]. Available from: http://data.europa.eu/eli/reg/2021/2282/oj.
3. POSA214 disentangling the complex interdependencies of reimbursement processes impeding funding of new medicines. A SWOT analysis of the Maltese system;Abraham;Value Health,2021
4. The transferability of health technology assessment: the European perspective with focus on central and Eastern European countries
5. PNS143 prioritization of drugs for reimbursement in the MALTESE health system;Abraham;Value Health,2019